Irrational medicine use and poor pharmaceutical management are widespread problems throughout all levels of Sierra Leone’s health system. Misuse, underuse, and overuse of medicines are particularly worrying because they contribute to the rise of antimicrobial resistance (AMR) and threaten the effective prevention and treatment of infections caused by bacteria, parasites, and viruses. Recognizing that coordinated […]
As part of World Antibiotic Awareness Week 2017, we present a Q&A with Mohan P. Joshi, MBBS, MSc, MD, SIAPS principal technical advisor. Dr. Joshi is responsible for providing technical guidance and support in the planning and implementation of rational medicine use and antimicrobial resistance (AMR)-related activities. Are there new AMR threats that are particularly worrying? […]
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA on November 9 2017.
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats —one that could erode gains against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread. Immediate, cross-cutting, and multidisciplinary action is required to adequately address the multidimensional drivers of AMR. In the health sector, strengthening the systems through which health services and medicines are provided is a prerequisite to making progress against AMR. This technical brief discusses how SIAPS is working to address AMR through a health system strengthening approach with interventions spanning the global, regional, national, and local levels.
This inventory is a selected list of resources and interventions that support antimicrobial resistance (AMR) containment. The objective of this inventory is to provide a list of key resources, tools, and interventions that create or strengthen systems that are necessary to improve antimicrobial use and AMR containment. Along with the full references, links are provided directly to the documents or to sites from where the documents can be downloaded. The intention is to periodically update the inventory as new resources, tools, and evidence-based interventions become available.
Antimicrobial resistance (AMR) is one of the world’s most pressing global health threats and could erode the progress made in the treatment of HIV/AIDS, tuberculosis, malaria, and many other infectious diseases. Although AMR occurs naturally, many interrelated factors, including excessive or inappropriate use of antibiotics, poor control practices, and infection prevention, contribute to its acceleration […]
Antimicrobial resistance (AMR) occurs when microorganisms develop a resistance to a medicine that was originally intended to disable or kill them. While microbes naturally develop resistance to antimicrobials over time, AMR is accelerated by the overuse and misuse of antimicrobial medicines and non-adherence to treatment regimens. AMR jeopardizes the effectiveness of complex surgeries and procedures […]
This guide aims to help individuals, organizations, and governments develop, establish, and maintain effective multidisciplinary and multisectoral coalitions to combat AMR. This document provides guidance on building and strengthening coalitions to combat AMR through five key elements. It primarily focuses on the creation and establishment of new coalitions; however, these elements are relevant throughout the lifespan of a coalition, and revisiting each periodically may be important as coalitions grow and evolve, expand in scope or wane and need to be revitalized. In addition, the elements of coalition building may not necessarily occur in strict sequential order. Depending on the context and existing systems in place, coalitions may be able to use situational analyses that have already been conducted or utilize an existing active network. In each setting, it is important to understand the needs of the coalition and focus on the elements of this guide that align best with those needs.
SIAPS partners with the University of Namibia to host the third international medicine utilization research symposium
SIAPS provided technical assistance to the University of Namibia-School of Pharmacy (UNAM-SoP) in organizing the third international Medicines Utilisation Research in Africa (MURIA) workshop and symposium in Windhoek, June 26–28, 2017. With the theme of “Medicine utilisation research in Africa, influencing patient care and policy”, the conference highlighted the importance of building the capacity of […]
by Aubrey Clark, MPH; Mohan P. Joshi, MBBS, MSc, MD Strong health systems are necessary to help prevent and mitigate epidemics, including the oft-overlooked epidemic of antimicrobial resistance. This post originally appeared on MSH’s Global Health Impact Blog as part of a new series on improving the health of the poorest and most vulnerable women, girls, families, […]
In November 2016, SIAPS offered technical assistance to DPMED to optimize the current medicine registration system, potentially by using the […]
- Therapeutics Information and Pharmacovigilance Centre's Analysis of Spontaneous Adverse Events due to Antiretroviral and Other Medicines
The use of antiretrovirals (ARVs) in combination for treating patients with HIV has greatly ameliorated morbidity and mortality by reducing […]
SIAPS worked with global and in-country partners to improve access to and use of life-saving medicines for women and children, […]